EUVIMEDEUVIMED entdecken
Crossref

Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models

Tomohiro Ohtani iD, Mari Ichinose iD, Takayuki Iriyama, Miho Irie, Yu Ariyoshi, Eriko Yano, Seisuke Sayama, Nobumi Suzuki, Yoku Hayakawa, Keiichi Kumasawa, Takeshi Nagamatsu, Miyuki Harada und 1 weitere

American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.06.2026 · 330 (6) · G704-G717

DOI: 10.1152/ajpgi.00401.2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.06.2026. Verfasst von Tomohiro Ohtani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Japan. Hauptthemen laut MEDLINE: Pre-Eclampsia, Fetal Growth Retardation, Lactoferrin, Enteritis. Die Arbeit nennt 68 Literaturangaben. Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), JAOG Ogyaa Donation Foundation, Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children born to mothers with preeclampsia are at an increased risk of postnatal intestinal vulnerability, yet the mechanisms of such disorders remain unclear. In murine preeclampsia models with fetal growth restriction, offspring exhibited impaired intestinal epithelial differentiation and markedly reduced lactotransferrin expression from fetal to postnatal stages. Prophylactic oral lactotransferrin mitigated experimental enteritis, highlighting a risk-based preventive strategy for postnatal intestinal disorders in infants exposed to intrauterine stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaFetal Growth RetardationLactoferrinEnteritisAnimalsFemalePregnancyMiceDisease Models, AnimalIntestinal MucosaMice, Inbred C57BL

Stichwörter der Autor:innen

fetal growth restrictionintestinal disorderintrauterine stresspreeclampsia

Substanzen

LactoferrinLtf protein, mouse

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
  • Department of Gastroenterology, Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
  • Department of Obstetrics and Gynecology, International University of Health and Welfare Narita Hospital, Narita, Japan.

ORCID-Profile: Tomohiro Ohtani, Mari Ichinose

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • JAOG Ogyaa Donation Foundation
  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Ohtani, T., Ichinose, M., Iriyama, T., Irie, M., Ariyoshi, Y., Yano, E., Sayama, S., Suzuki, N., Hayakawa, Y., Kumasawa, K., Nagamatsu, T., Harada, M., & Hirota, Y. (2026). Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models. American Journal of Physiology-Gastrointestinal and Liver Physiology, 330(6), G704-G717. https://doi.org/10.1152/ajpgi.00401.2025

Vancouver

Ohtani T, Ichinose M, Iriyama T, Irie M, Ariyoshi Y, Yano E, et al. Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2026;330(6):G704-G717. doi:10.1152/ajpgi.00401.2025

BibTeX
@article{Ohtani2026,
  author = {Ohtani, Tomohiro and Ichinose, Mari and Iriyama, Takayuki and Irie, Miho and Ariyoshi, Yu and Yano, Eriko and Sayama, Seisuke and Suzuki, Nobumi and Hayakawa, Yoku and Kumasawa, Keiichi and Nagamatsu, Takeshi and Harada, Miyuki and Hirota, Yasushi},
  title = {Lactotransferrin reduction as a target mechanism of postnatal intestinal vulnerability in murine preeclampsia models},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2026},
  volume = {330},
  number = {6},
  pages = {G704--G717},
  doi = {10.1152/ajpgi.00401.2025}
}
Kostenlos starten →